Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 13 % of short-term debt in 2024; threshold 65 %.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2024
M.D.C. from Brussel, company number BE0424826247, closed financial year 2024 with a result of € -42,238 after tax. For that financial year M.D.C. recorded a gross margin of € 103,385 and equity of € 146,227. Compared with financial year 2023, the result moved from € 2,393 to € -42,238. The company made a loss. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2025.
€ 146,227
▼ 22% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -42,238
▼ still € 2,393 profit in 2023
Profit after tax over the fiscal year.
€ 7,796
▲ 120% vs 2023
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 115,241.
Debts at end 2024
€ 931,130
▼ 9% vs 2023
€ 101,134 is repaid this year. At this pace the long-term loan is gone in ≈ 9 years.
€ 246,547
▲ 20% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 682
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 163,353 | € 140,523 | € 133,773 | € 103,385 | ▼ 23% |
| Profit after taxes | € 85,095 | € 45,687 | € 2,393 | € -42,238 | ▼ € 44,631 |
| Equity | € 145,056 | € 186,071 | € 188,465 | € 146,227 | ▼ 22% |
| Total debts | € 1,683,608 | € 1,799,314 | € 1,731,082 | € 1,726,235 | |
| Cash | € 7,099 | € 4,250 | € 3,547 | € 7,796 | ▲ 120% |
| Land & buildings | € 1,531,813 | € 1,730,368 | € 1,779,101 | € 1,749,907 | ▼ 2% |
| Retained profit | € 114,069 | € 155,085 | € 157,478 | € 115,241 | ▼ 27% |
| Bank debt | € 1,215,284 | € 1,120,821 | € 1,027,490 | € 931,130 | ▼ 9% |
| Balance sheet total | € 1,884,754 | € 2,039,229 | € 1,971,144 | € 1,921,812 | ▼ 3% |
Key figures of M.D.C., fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to M.D.C.?
What happened at M.D.C. in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: loss of € 42,238 (▼ € 44,631 vs 2023). filed late Source: NBB ↗
- New establishment in Gembloux. KBO
- Start of the company according to the CBE. KBO
In short
From € 85,095 profit in 2021 to € 42,238 loss in 2024.
Best year ever: 2021, with € 85,095 profit.
A new publication or filing at M.D.C.? We notify you, reason included.
Follow M.D.C.Databakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of EVALEM BETA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
M.D.C.Behind M.D.C. are Class-Business and GEGEM SRL. The shares are held by EVALEM BETA (100%).
Directors
According to the 2024 annual accounts
Director · represented by Etienne de Sauvage Vercour
Also active at: EVALEM ALPHA, CLASS-FINANCE, LES HAUTS DE MERBRAINE, CLASS-CONSTRUCT, CLASS - INVEST, GESTION DE GEMBLOUX
Director · represented by Etienne de Sauvage Vercour
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Louizalaan 131 box A
1050 Brussel
Rue des Tilleuls, Gd-M. 7
5030 Gembloux
Active since 29 March 1993
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 7 companies are registered at this address.
All companies at this address →EVALEM BETA same network
€ 194,141 gross margin · 2024
Bureau d'Achat et de Vente
€ -44,804 gross margin · 2025
OLD IMPEXCO
DEAL S.C. Bourse d'Affaires de Bruxelles
CLASS - INVEST same network
€ 236,138 gross margin · 2024
+2 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0424.826.247
- VAT number
- BE 0424.826.247
- Registered office
- Louizalaan 131 bus A, 1050 Brussel
- Names & denominations
- M.D.C.
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 21 November 1983
- Peppol
- Not registered
- Activities · NACE
Activiteiten van ingenieurs en aanverwante technische adviseurs, exclusief landmeters-experts
Technische studiën en ingenieursactiviteiten